The Chemours Company (CC)
$
21.6
+0.02 (0.09%)
Key metrics
Financial statements
Free cash flow per share
0.3392
Market cap
3.2 Billion
Price to sales ratio
0.5582
Debt to equity
18.3400
Current ratio
1.7800
Income quality
-0.7116
Average inventory
1.6 Billion
ROE
-1.1320
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
The Chemours Company, founded in 2014 and headquartered in Wilmington, Delaware, provides performance chemicals across several global regions, including North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment specializes in TiO2 pigment under the Ti-Pure and BaiMax brands, which deliver essential properties such as whiteness, brightness, opacity, and protection across a range of applications, including architectural and industrial coatings, plastic packaging, and laminate papers. The Thermal & Specialized Solutions segment focuses on refrigerants, thermal management solutions, and foam blowing agents, while the Advanced Performance Materials portfolio contains industrial resins, specialty products, and coatings for various sectors, including consumer electronics and semiconductors. The Chemical Solutions segment offers industrial chemicals vital for multiple uses, such as gold production and water treatment. The company recorded an operating income of -$5,000,000.00 reflecting its earnings from core operations. The weighted average number of shares outstanding is $150,351,421.00 highlighting the company's shareholder base. The financial data pertains to the fiscal year $2025 with operating expenses amounting to $907,000,000.00 showcasing the various costs incurred in operations. Additionally, the company earned an interest income of $0.00 illustrating its financial investments in diverse areas. In the investment landscape, the company's stock is affordable at $17.01 making it a suitable option for budget-conscious investors. It features a high average trading volume of 3,491,528.00 indicating strong liquidity that can support active trading strategies. With a mid-range market capitalization of $3,241,836,000.00 the company exemplifies steady performance within its sector. It is a key player in the Chemicals - Specialty industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Basic Materials sector, driving innovation and growth, which presents prospects for future developments that investors may find appealing.
Is The Chemours Company (CC) a good investment?
Investing in The Chemours Company (CC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as D+, with a Bullish outlook. Always conduct your own research before investing.
What is The Chemours Company (CC)'s stock forecast?
Analysts predict The Chemours Company stock to fluctuate between $9.13 (low) and $21.87 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is The Chemours Company's market capitalization?
As of 2026-03-27, The Chemours Company's market cap is $3,241,836,000, based on 150,085,000 outstanding shares.
How does The Chemours Company compare to competitors like Southern Copper Corporation?
Compared to Southern Copper Corporation, The Chemours Company has a Lower Market-Cap, indicating a difference in performance.
Does The Chemours Company pay dividends?
The Chemours Company pays dividends. The current dividend yield is 1.92%, with a payout of $0.09 per share.
How can I buy The Chemours Company (CC) stock?
To buy The Chemours Company (CC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CC. Place an order (Market, Limit, etc.).
What is the best time to invest in The Chemours Company?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did The Chemours Company perform in the last earnings report?
Revenue: $5,808,000,000 | EPS: -$2.57 | Growth: -543.10%.
Where can I find The Chemours Company's investor relations reports?
Visit https://www.chemours.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for The Chemours Company?
You can explore historical data from here
What is the all-time high and low for The Chemours Company stock?
All-time high: $44.95 (2022-06-06) | All-time low: $9.13 (2025-06-02).
What are the key trends affecting The Chemours Company stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
The article analyzes the Canton Network and its CIP-0105 update, which incentivizes Super Validators to lock rewards, aligning interests with long-term network success. CIP-0105 could result in 20–32% of Canton Coin supply being locked over the long run, reducing circulating supply and disincentivizing opportunistic selling. Major financial institutions like Nasdaq, DTCC, and others serve as Super Validators, signaling strong institutional adoption and potential for network effects.
prnewswire.com
WILMINGTON, Del., March 12, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $700,000,000 in aggregate principal amount of 7.875% senior unsecured notes due 2034 (the "Notes") that was exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").
globenewswire.com
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
prnewswire.com
NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
prnewswire.com
WILMINGTON, Del., Feb. 26, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of $700,000,000 aggregate principal amount of new 7.875% senior notes due 2034 (the "Notes").
prnewswire.com
NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
prnewswire.com
Successful qualification of Opteon™ fluid in 2CRSi server sparks broader collaboration to drive innovation in new and existing technologies across respective portfolios WILMINGTON, Del. and STRASBOURG, France, Feb. 24, 2026 /PRNewswire/ -- The Chemours Company (NYSE: CC), a global chemistry company, and 2CRSi (ISIN code: FR0013341781), a pioneer in high-performance, eco-responsible server technology, today announced a Joint Development Agreement (JDA)1 following the successful qualification of Chemours' Opteon™ two-phase immersion cooling fluid in current-generation 2CRSi servers.
seekingalpha.com
Chemours Company is downgraded to "Hold" after a sharp rally, with shares now fairly valued around $18. CC's TSS segment benefits from Opteon adoption and future data center demand, but other units face ongoing macro headwinds. Leverage remains elevated at 4.7x; asset sales and cash flow should reduce leverage to 4x by year-end, but further progress will be slow.
prnewswire.com
Advanced Performance Materials business president to help guide SEMI's efforts supporting North America's semiconductor innovation and supply chain resilience WILMINGTON, Del., Feb. 23, 2026 /PRNewswire/ --The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced that Gerardo Familiar, President of the company's APM business, has been appointed to the SEMI North America Advisory Board (NAAB).
zacks.com
CC posts a wider y/y loss in Q4 as sales dip 2%, but the bottom line beats estimates and Thermal & Specialized Solutions surges on strong refrigerant pricing.
See all news
